Techniques and Outcomes of Transjugular Intrahepatic Portosystemic Shunting in Infants with Budd-Chiari Syndrome.
Budd-Chiari Syndrome
/ diagnostic imaging
Child
End Stage Liver Disease
Esophageal and Gastric Varices
Gastrointestinal Hemorrhage
Humans
Liver Transplantation
/ adverse effects
Living Donors
Male
Portasystemic Shunt, Transjugular Intrahepatic
/ adverse effects
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Journal
Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
16
12
2020
revised:
23
08
2021
accepted:
30
08
2021
pubmed:
18
9
2021
medline:
24
3
2022
entrez:
17
9
2021
Statut:
ppublish
Résumé
To describe the technical aspects, feasibility, and outcomes in children with Budd-Chiari syndrome (BCS) undergoing transjugular intrahepatic portosystemic shunt (TIPS) creation during infancy. A retrospective review of infants with BCS undergoing TIPS creation between January 2012 and December 2018 was performed. Eight infants (5 males) underwent TIPS creation (7 for refractory ascites and 1 for refractory variceal bleeding) during the study period. The median age at TIPS creation was 10.5 months (range, 8-16 months). The median elapsed time between presentation and TIPS creation was 6.5 months (range, 0-13 months). The median weight and median pediatric end-stage liver disease score of the infants at the time of TIPS creation were 6.7 kg (range, 5.4-10 kg) and 13 kg (range, 8-18 kg), respectively. TIPS creation was successful in all patients. There were no immediate postprocedural complications. An 18-gauge hollow needle was manually curved, through which a 21-gauge Chiba needle was inserted to access the portal vein. All patients received 1 or 2 overlapping bare metal stents. One patient was lost to follow-up after the procedure. The median follow-up duration was 32 months (range, 14-51 months). Four of 7 infants needed reintervention. Two children died during the follow-up period. Two children successfully underwent living donor liver transplant, whereas the remaining 3 children were asymptomatic at the follow-up. TIPS creation was found to be safe and efficacious in improving portal hypertension and growth in these children, although, with a higher rate of reinterventions, possibly due to the use of small, bare metal stents.
Identifiants
pubmed: 34534652
pii: S1051-0443(21)01347-6
doi: 10.1016/j.jvir.2021.08.023
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1637-1643Informations de copyright
Copyright © 2021 SIR. Published by Elsevier Inc. All rights reserved.